Mesenchymal Stem Cell‐Driven Neurotrophic Bioelectronic Platform (MSC‐NBP) Potentiated Peripheral Nerve Regeneration
Advanced Functional Materials · 2026-03 · 36 (25)
DOI: 10.1002/adfm.202523049 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Functional Materials, online erschienen am 17.11.2025. Verfasst von Linhao Yuan und 14 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Capital Health Research and Development of Special Fund, Natural Science Foundation of Beijing Municipality.
Abstract (Originalsprache)
Peripheral nerve injury (PNI) causes persistent sensory and motor deficits, and current surgical repairs fail to fully restore function due to insufficient axonal regeneration, remyelination, and immune modulation. Mesenchymal stem cells (MSCs) offer neurotrophic and immunoregulatory benefits, but post‐transplant survival and activation are suboptimal. Electrical stimulation (ES) promotes axonal growth and myelination, yet as a stand‐alone intervention, ES delivers imprecise dosing, risks device‐related injury, and offers no biological support. Here, a Mesenchymal Stem Cell‐Driven Neurotrophic Bioelectronic Platform (MSC‐NBP) that integrates umbilical cord‐derived MSCs encapsulated in molybdenum nanoparticle‐doped GelMA conductive hydrogel with a skin‐activated, wireless ES device, is presented. The Gel/Mo scaffold provides injectability, rapid in situ crosslinking, tunable mechanics, and high conductivity to ensure stable ES dosing and intimate nerve interfacing. In vitro, ES reprogrammes MSCs toward Schwann cell‐like phenotypes, significantly enhancing secretion of BDNF, NGF, and IL‐10 and supporting neuronal axon elongation and activity. Single‐cell transcriptomics reveal upregulation of neuroregenerative pathways and strengthen MSC‐Schwann cell interactions. In vivo, MSC‐NBP achieves superior gait recovery, muscle preservation, electrophysiological improvement, and histological regeneration compared to single‐modality controls, with confirmed long‐term biosafety. This integrative bioelectronic‐cellular platform offers a mechanism‐driven and clinically translatable strategy for maximizing PNI repair.
Förderung
- National Natural Science Foundation of China
- Capital Health Research and Development of Special Fund
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Yuan, L., Zhu, Y., Li, J., Jiang, C., Xu, Q., Wang, X., Liu, X., Wang, X., Zhang, A., Zhang, T., Yang, H., Ma, S., Kang, P., Zhou, W., & Jia, W. (2026). Mesenchymal Stem Cell‐Driven Neurotrophic Bioelectronic Platform (MSC‐NBP) Potentiated Peripheral Nerve Regeneration. Advanced Functional Materials, 36(25). https://doi.org/10.1002/adfm.202523049
Vancouver
Yuan L, Zhu Y, Li J, Jiang C, Xu Q, Wang X, et al. Mesenchymal Stem Cell‐Driven Neurotrophic Bioelectronic Platform (MSC‐NBP) Potentiated Peripheral Nerve Regeneration. Advanced Functional Materials. 2026;36(25). doi:10.1002/adfm.202523049
BibTeX
@article{Yuan2026,
author = {Yuan, Linhao and Zhu, Yetian and Li, Jiang and Jiang, Chenggang and Xu, Qin and Wang, Xi and Liu, Xiangxiang and Wang, Xu and Zhang, Aobo and Zhang, Tieqiang and Yang, Hao and Ma, Shunchang and Kang, Peng and Zhou, Wenjianlong and Jia, Wang},
title = {Mesenchymal Stem Cell‐Driven Neurotrophic Bioelectronic Platform (MSC‐NBP) Potentiated Peripheral Nerve Regeneration},
journal = {Advanced Functional Materials},
year = {2026},
volume = {36},
number = {25},
doi = {10.1002/adfm.202523049}
}
EUVIMED